Popular debate sessions return to #ISC21
Tudor Jovin, MD
“This year, the debate topics are particularly exciting because they include novel management approaches (acute or preventive) that remain controversial in clinical practice due to lack of definitive data supporting their use over established practice,” said Tudor Jovin, MD, ISC 21 program vice chair.
Louise D. McCullough, MD, PhDPhoto credit: UTHealth
“These debates highlight some of the nuances and unknowns we all experience when caring for stroke patients. Sometimes, there is more than one right approach,” said Program Chair Louise D. McCullough, MD, PhD.
See the Online Program Planner for times and dates of these debates:
- Challenging EVT Decision Making: When, Where and Who to Treat
- COVID-19 Debates: General Anesthesia Versus Conscious Sedation? / Coagulopathy or Endotheliopathy?
- CT, CTA, Perfusion or Multiphase CTA in the Spoke Versus the Hub: Optimal Acute Stroke Evaluation
- In the Age of Thrombectomy, Does Thrombolysis Have a Role in LVO Treatment?
- Knowns and Unknowns in Intracerebral Hemorrhage Treatment
- Mismatch Misalignments for Extended-Window IV-thrombolysis for Non-Large Vessel Occlusion Strokes
- Tenecteplase Is Ready for Clinical Practice
- The Unruptured Aneurysm — Follow, Treat, Refer?
- To Treat or Not to Treat, and If So, How? Up-to-Date Perspective on the Treatment of Cervical Carotid High-Degree Stenosis
- Treatment of Acute Stroke in Childhood and Young Adults
Register today so you won’t miss out.
